Mauna Kea Technologies postpones release of its 2022 Half-Year Results, which was originally planned for September 22, 2022, to not later than October 31, 2022. The delay reflects the diversion of management resources as required to implement the Company's previously announced joint venture with Tasly Pharmaceutical. The company will release its new financial calendar shortly.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 EUR | +0.38% | +2.56% | -15.07% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.07% | 26.52M | |
-42.33% | 2.84B | |
+17.00% | 1.85B | |
-0.51% | 1.66B | |
+27.15% | 1.26B | |
-13.90% | 989M | |
-21.76% | 896M | |
-2.72% | 757M | |
-23.95% | 633M | |
+6.84% | 500M |
- Stock Market
- Equities
- ALMKT Stock
- News Mauna Kea Technologies
- Mauna Kea Technologies Postpones Release of its 2022 Half-Year Financial Results